Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anabolic Therapy in Postmenopausal Osteoporosis

NCT05010590 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT05010590
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05010590 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anabolic Therapy in Postmenopausal Osteoporosis
Lead sponsor
Massachusetts General Hospital
Phase
Phase 4
Overall status
Active, not recruiting
Start date
March 24, 2022
Completion date
November 1, 2027
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

postmenopausal osteoporosis